CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 101 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2020. The put-call ratio across all filers is 0.24 and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,871,000 | -24.9% | 79,975 | -7.6% | 0.02% | -11.1% |
| Q4 2020 | $2,493,000 | -47.6% | 86,557 | -63.1% | 0.03% | -70.3% |
| Q3 2020 | $4,756,000 | +244.1% | 234,741 | +410.3% | 0.09% | +145.9% |
| Q2 2020 | $1,382,000 | +46.6% | 46,000 | +53.3% | 0.04% | -5.1% |
| Q1 2020 | $943,000 | -19.9% | 30,000 | +20.0% | 0.04% | 0.0% |
| Q4 2019 | $1,178,000 | – | 25,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $36,821,000 | 28.20% |
| Ponoi Management, LLC | 1,880,623 | $43,988,000 | 25.87% |
| VR Adviser, LLC | 4,016,873 | $93,955,000 | 10.19% |
| Column Group LLC | 2,626,631 | $61,437,000 | 5.89% |
| Euclidean Capital LLC | 554,325 | $12,966,000 | 4.34% |
| GREAT POINT PARTNERS LLC | 872,415 | $20,406,000 | 4.22% |
| Venrock Management V, LLC | 1,570,058 | $36,724,000 | 3.76% |
| COMMODORE CAPITAL LP | 368,448 | $8,618,000 | 3.43% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 621,541 | $14,538,000 | 1.90% |
| Bain Capital Life Sciences Investors, LLC | 1,400,000 | $32,746,000 | 1.86% |